<description>&lt;p&gt;Interview with Sajid A. Khan, MD, author of Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. Hosted by Mary L. (Nora) Disis, MD.&lt;br /&gt; &lt;br /&gt; &lt;strong&gt;Related Content:&lt;/strong&gt;&lt;/p&gt; &lt;ul&gt; &lt;li&gt;&lt;a class="related-article" href= "https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2023.6025?utm_source=podcast_platforms&amp;utm_medium=referral&amp;utm_campaign=related_article_links" target="_blank" rel="noopener"&gt;Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US&lt;/a&gt;&lt;/li&gt; &lt;/ul&gt;</description>

JAMA Oncology Author Interviews

JAMA Network

Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

JAN 4, 202417 MIN
JAMA Oncology Author Interviews

Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

JAN 4, 202417 MIN

Description

Interview with Sajid A. Khan, MD, author of Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. Hosted by Mary L. (Nora) Disis, MD. Related Content: